Home › Activist investors › Value Base Ltd.
Campaign activist. Positions and campaigns from Value Base Ltd.’s SEC filings. Updated November 20, 2026.
Active campaign Public letter or presentation filed · Mar 26, 2026
| Company | Stake | Source | First disclosed | Last change | Since previous filing | Flags | Stated intent |
|---|---|---|---|---|---|---|---|
| RadCom Ltd | 5.3%865,009 shares | Schedule 13D/A, filed Mar 26, 2026 | Feb 17, 2026 | — | 0.00 pts | Active campaign | Seeks changes or engagement |
| Valens Semiconductor Ltd. | 20.8%21,299,896 shares | Schedule 13D/A, filed Nov 24, 2025 | Jul 23, 2024 | Increased Nov 24, 2025 | ▲ 1.36 pts | — | Standard Item 4 language |
| Teads Holding Co. | 5.87%5,752,107 shares | 13F, quarter ended Sep 30, 2026filed Nov 10, 2026; % of shares outstanding as of Jul 31, 2026 | Feb 11, 2025 | — | 0.00 pts | — | 13F: none stated |
| Perion Network Ltd | 5.6%2,528,710 shares | Schedule 13D/A, filed Jul 14, 2025 | Apr 21, 2025 | Decreased Jul 14, 2025 | ▼ 0.16 pts | — | Standard Item 4 language |
| Cognyte Software Ltd. | — | Schedule 13D/A, filed Sep 16, 2024stake not read from this filing’s format: see the filing | Jun 26, 2024 | — | — | — | Standard Item 4 language |
Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.
Item 4 of a Schedule 13D (“Purpose of Transaction”) is where the investor states its plans. The label is a plain reading of that text; the excerpt is quoted from the filing.
“…directors appointed by the Board of Directors to fill vacancies prior to the Special Meeting shall terminate upon the conclusion of the Special Meeting, (iv) remove the following directors from the Company's Board of Directors, effective as of the conclusion of the Special Meeting: Rami Schwartz, Rachel (Hili) Bennun, Oren Most, Yaron Ravkeie and Andre Feutch, (v) nominate for election by shareholders of the following candidates for the Board of Directors…”
“Item 4 of the Schedule 13D is amended to add the following: In consideration for Mr. Yaacobi's services as a director, the Issuer made certain equity grants to Mr. Yaacobi on March 12, 2025 through a company wholly-owned by Mr. Yaacobi. These equity grants were as follows: (1) A total of 35,689 options to purchase Ordinary Shares of the Issuer (the "Options"), granted pursuant to the Issuer's 2021”
“Item 4 of the Schedule 13D is amended to add the following: On July 14, 2025, VBF LP, through its external legal counsel, sent a letter to the Chairman of the Board of Directors of the Company (the "Additional Letter") welcoming the Company's decision to remove the previously adopted rights plan and highlighting, for the last time, several additional concerns that VBF LP believes the Board of Directors…”
“Item 4 of the Schedule 13D is amended to add the following: On August 27, 2024, the Reporting Persons issued a presentation titled “Value Base Group’s 2024 Value Creation Plan for Cognyte Software Ltd.” (the “ Presentation ”). A copy of the Presentation is filed herewith as Exhibit 6 and incorporated herein by reference. The description of the presentation contained in this Amendment No. 4 is qualified…”
Item 4 in the Schedule 13D/A filed Sep 16, 2024; this amendment did not restate Item 4, so the text is from the filing of Aug 27, 2024.
| Company | Last stake | Source | Outcome | Date |
|---|---|---|---|---|
| SHL Telemedicine LTD | 15.2% | Schedule 13D/A, filed Dec 5, 2025 | Not in the 13F for the quarter ended Dec 31, 2025 | Feb 9, 2026 |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| RadCom Ltd | Ongoing | Public letter or presentation filed | Mar 26, 2026 | Feb 17, 2026 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 1 of 5 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
| Company | First 13D | To latest close | SPY same dates | 6 months after | 12 months after |
|---|---|---|---|---|---|
| RadCom Ltd RDCM | Feb 17, 2026 | -7.3%Feb 17, 2026 – Nov 18, 2026 | +6.9% | -15.6%SPY +12.6% | not yet / no price |
Prices: daily closes (Nasdaq), as stored by the site.
Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Value Base Ltd.’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.
| Holder | Form | Date | Stake |
|---|---|---|---|
| Lynrock Lake LP | Schedule 13D | Feb 24, 2026 | 19.3% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Phoenix Financial Ltd. | Schedule 13D | Jun 30, 2025 | 5.7% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Patrick Drahi | Schedule 13D | Feb 10, 2025 | 46.8% |
| Holder | Form | Date | Stake |
|---|---|---|---|
| Danbar Finance Ltd. | Schedule 13D | Dec 26, 2023 | 4.9% |